JNJ-61803534,99.88%
产品编号:Bellancom-139780| CAS NO:1917306-14-9| 分子式:C23H23Cl2F6N3O4S| 分子量:622.41
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
JNJ-61803534
产品介绍 | JNJ-61803534 是一种有效的、具有口服活性 RORγt 反向激动剂,IC50 为 9.6 nM。JNJ-61803534 具有抗炎活性。JNJ-61803534 在 Th17 分化条件下抑制人 CD4+ T 细胞产生 IL-17A。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | JNJ-61803534 is a potent and orally active RORγt inverse agonist with an IC50 of 9.6 nM. JNJ-61803534 has anti-inflammatory activity. JNJ-61803534 inhibits IL-17A production in human CD4+ T cells under Th17 differentiation conditions. | ||||||||||||||||
体外研究 |
JNJ-61803534 在转染了编码 RORγt 载体的 HEK-293 T 细胞中抑制 RORγt 转录,IC50 为 9.6 nM。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
JNJ-61803534 (100 mg/kg,口服) 抑制小鼠血液中体外刺激产生的 IL-17A。 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
体内研究 |
JNJ-61803534 (100 mg/kg,口服) 抑制小鼠血液中体外刺激产生的 IL-17A。 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 300 mg/mL (482.00 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
参考文献 |